Brand Intelligence Graph
Company Overview
About Cytotheryx
Cytotheryx is a Mayo Clinic spinout developing human hepatocytes (liver cells) produced at scale using genetically engineered pigs as bio-incubators. The company raised $60 million in Series A financing in January 2026 led by Ouroboros Capital, with GMP (Good Manufacturing Practice) manufacturing expansion underway to support both its acute liver failure support program and transplant-grade cell therapy pipeline.
Business Model & Competitive Advantage
The core innovation is using proprietary genetically engineered pigs whose livers can host and expand functional human hepatocytes — a process called xenogeneic amplification. Human hepatocytes produced this way maintain their functional properties (drug metabolism, protein synthesis, bile production) and can be cryopreserved and distributed as an off-the-shelf therapeutic product. This addresses a critical bottleneck in liver disease treatment: human hepatocytes are in chronic short supply because they cannot be meaningfully expanded in vitro.
Competitive Landscape 2025–2026
Cytotheryx's pipeline has two near-term applications: bioartificial liver support for patients in acute liver failure (where a hepatocyte-seeded extracorporeal device buys time for liver recovery or transplant), and cell transplantation for metabolic liver diseases where replacing a subset of dysfunctional hepatocytes could be curative. The Mayo Clinic pedigree provides both clinical relationships and rigorous translational research infrastructure.
Key Differentiators
Emerging Innovator
Cytotheryx is an emerging player bringing innovative solutions to the BioTech market.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Emulate
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m
ConcertAI
ConcertAI is a Boston-based company that combines artificial intelligence with real-world oncology data to accelerate cancer drug development and improve patient outcomes. Its platform integrates mult
DNAnexus
DNAnexus is the category-defining cloud platform for precision health data management, analysis, and collaboration. Founded in 2009 and headquartered in Mountain View, California, DNAnexus provides a
Saluda Medical
Saluda Medical is a commercial-stage medical device company that has pioneered closed-loop neuromodulation therapy for chronic pain management. Headquartered in Macquarie Park, Australia (with US oper
Tempus
Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder o
Schrödinger
Schrödinger was founded in 1990 by Richard Friesner and David Pearlman in New York City, building physics-based computational methods for molecular simulation. For over 30 years the company has develo
Compare Cytotheryx with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Cytotheryx? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Cytotheryx Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Cytotheryx vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →